Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Unspecified Adult Solid Tumor, Protocol Specific
Interventions: BIOLOGICAL: allogeneic GM-CSF-secreting breast cancer vaccine|BIOLOGICAL: recombinant interferon alfa|DRUG: cyclophosphamide
Sponsor: Wiseman Research Initiatives LLC